Zoloft Patent Dispute: FTC Sides With Teva On Declaratory Judgment Rights

The Federal Trade Commission is supporting Teva's effort to use the declaratory judgment process in patent litigation with Pfizer over Zoloft

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet